Red cell distribution width, or RDW, is a number on your complete blood count (CBC) that measures how much your red blood cells vary in size. A normal RDW typically falls between about 11.5% and 14.5%, and when it runs high, it signals that your red blood cells are coming in a wider-than-usual range of sizes. That variation itself is not a disease; it is a clue pointing toward something else going on, from straightforward nutritional deficiencies to chronic inflammation or organ disease. The list of conditions linked to an elevated RDW has grown considerably in recent years, which makes this once-overlooked lab value more interesting than it first appears.
What RDW Actually Measures
Every time your bone marrow releases red blood cells, they are not all identical in volume. Some are a little larger, some a little smaller. RDW quantifies that spread. Specifically, it is calculated by dividing the standard deviation of your red blood cell volumes by the mean corpuscular volume (MCV), then multiplying by 100 to express it as a percentage.1SpringerOpen. Red Blood Cells Mean Corpuscular Volume (MCV) and Red Blood Distribution Width (RDW) Parameters as Potential Indicators of Regenerative Potential in Older Patients and Predictors of Acute Mortality A low number means your red blood cells are roughly uniform in size. A high number means there is a conspicuous mix of large and small cells circulating together, a condition sometimes called anisocytosis.
Your doctor almost never orders an RDW test on its own. It arrives automatically as part of a standard CBC, which most blood panels include. That means you may have had your RDW measured dozens of times without paying attention to it. Most people only notice the number when it comes back flagged as abnormal.
RDW-CV Versus RDW-SD
If you look closely at your lab report, you might see two versions of RDW listed. RDW-CV is the coefficient of variation, the percentage value described above. RDW-SD is a different measurement: it represents the width of the red blood cell volume distribution curve at a specific point and is reported in femtoliters rather than as a percentage.2J. Bras. Patol. Med. Lab.. Evaluation of RDW-CV, RDW-SD, and MATH-1SD for the detection of erythrocyte anisocytosis observed by optical microscopy Both track the same underlying concept, but because RDW-CV is calculated relative to MCV, it can be skewed when MCV is very high or very low. RDW-SD is an absolute measurement, so it can sometimes catch size variation that RDW-CV misses. In chronic kidney disease, for example, both are used as prognostic markers, though they do not always move in lockstep.3AVERROUS: Jurnal Kedokteran dan Kesehatan Malikussaleh. Comparison of RDW-SD and RDW -CV in Chronic Kidney Disease Patients Before and After Hemodialysis In routine clinical practice, RDW-CV is the value most commonly referenced, and a result above roughly 14.5% is the usual threshold for “high.”
Why Doctors Pair RDW with MCV
An elevated RDW by itself does not point to a single diagnosis. The number becomes far more useful when your doctor reads it alongside MCV, which tells you the average size of your red blood cells. The combination narrows down possibilities. A classification system built around this pairing groups red blood cell disorders into six categories based on whether MCV is low, normal, or high, crossed with whether RDW is normal or elevated.4PubMed. Evaluation of erythrocyte disorders with mean corpuscular volume (MCV) and red cell distribution width (RDW) This framework helps distinguish, for instance, iron deficiency anemia from a genetic hemoglobin condition called beta-thalassemia trait, both of which produce small red blood cells but differ in how uniform those cells are.5American Journal of Clinical Pathology. Improved Classification of Anemias by MCV and RDW
In iron deficiency, your body struggles to produce normal-sized red blood cells, so it churns out a mix of undersized and normal ones. That pushes RDW up. In beta-thalassemia trait, red blood cells tend to be uniformly small, so MCV drops but RDW often stays closer to normal. That distinction matters because iron deficiency is treated with supplements, while thalassemia trait generally requires no treatment at all. Studies evaluating diagnostic indices built from RDW and MCV have found sensitivities in the 80% to 96% range for separating these two conditions.6Italian Journal of Medicine. Mentzer Index and Red Cell Distribution Width Index in differentiating iron deficiency anemia and β-thalassemia trait The RDW is a guide to narrow down the diagnosis, not a definitive answer on its own.4PubMed. Evaluation of erythrocyte disorders with mean corpuscular volume (MCV) and red cell distribution width (RDW)
The Nutritional Deficiency Connection
The most common and most treatable reasons for a high RDW are nutritional deficiencies, particularly iron, vitamin B12, and folate. Each of these nutrients plays a role in how your bone marrow builds red blood cells, and when supply runs short, the cells that get produced are abnormally sized.
Vitamin B12 deficiency provides a striking example. In pernicious anemia, where the body cannot absorb B12 properly, the average RDW has been measured at about 21.7%, compared to roughly 13.2% in healthy controls.7PubMed. Red blood cell distribution width in untreated pernicious anemia That is a dramatic gap. In a study of 100 people with B12 deficiency, elevated RDW-SD was seen in 90% of cases, while elevated RDW-CV was seen in 72%.8National Journal of Laboratory Medicine. Discriminant Functions in the Diagnosis of Vitamin B12 Deficiency Anemia, the Value of RDW-SD: An Analytical Study The RDW-SD version was more sensitive in this case, which makes sense: B12 deficiency tends to make cells larger on average, and when MCV is high, RDW-CV can underrepresent the true degree of size variation.
Folate deficiency works through a similar mechanism and produces comparable RDW elevation. Iron deficiency, the most common nutritional anemia worldwide, typically shows up as small red blood cells with a high RDW. The practical takeaway is that if your RDW is elevated and your hemoglobin is low, your doctor will probably check your iron, B12, and folate levels before looking for anything more exotic.
Inflammation and Chronic Disease
Here is where RDW gets more complicated. A growing body of research links elevated RDW not just to anemia but to chronic inflammatory states, even in people whose hemoglobin looks fine. Inflammatory molecules can interfere with red blood cell production in the bone marrow, disrupting the orderly process of building cells of uniform size. Oxidative stress adds to the problem by damaging cell membranes and altering how cells develop.9PubMed Central. Red Blood Cell Distribution Width: A Potential Inexpensive Marker for Disease Activity in Patients with Rheumatic Diseases; Scoping Review
In autoimmune conditions like rheumatoid arthritis and lupus, elevated RDW has been tied to disease activity. The connection is thought to run through the same pro-inflammatory pathways: cytokines disrupt iron metabolism and red cell production, resulting in more size variation. Chronic liver disease follows a similar pattern, with ongoing inflammation impairing the bone marrow’s ability to use iron and B12 effectively, which in turn raises RDW.10PubMed Central. The Role of Red Cell Distribution Width as a Prognostic Marker in Chronic Liver Disease: A Literature Review Kidney disease does this too, partly because the kidneys produce erythropoietin, the hormone that stimulates red blood cell production. When kidney function declines, erythropoietin drops, and anisocytosis frequently follows.11PubMed Central. Red blood cell distribution width: A marker of anisocytosis potentially associated with atrial fibrillation
This inflammatory connection is worth understanding because it explains why your RDW might be elevated even though your iron, B12, and folate levels all look normal. Inflammation itself, acting through several pathways at once, can nudge RDW upward without producing a clean-cut nutritional deficiency picture.
RDW and Heart Failure
One of the more surprising research developments around RDW has been its consistent association with heart disease outcomes, particularly heart failure. Elevated RDW at hospital admission has been linked to worse prognosis in people with both acute and chronic heart failure, and it has been incorporated into several heart failure prognostic models.12PubMed Central. Red Blood Cell Distribution Width in Heart Failure: Pathophysiology, Prognostic Role, Controversies and Dilemmas Perhaps more striking, elevated RDW also predicts the risk of developing heart failure in people who do not yet have it.13PubMed Central. Red blood cell distribution width in heart failure: A narrative review
Why would red blood cell size variation have anything to do with the heart? The likely explanation is that RDW serves as a downstream marker of the same processes that damage the cardiovascular system: chronic inflammation, oxidative stress, poor nutritional status, and impaired kidney function. It is not that misshapen red blood cells are hurting the heart. Rather, the body-wide stress that produces heart failure also scrambles red blood cell production. Think of it as a shared thermometer reading rather than a cause-and-effect relationship. That said, the association is robust enough that some researchers have argued for using RDW as a cheap, readily available risk-stratification tool in cardiac patients, since the test is already included in routine blood work.
RDW as a Mortality Marker
The research finding that tends to alarm people most is the link between elevated RDW and death from all causes. A large study of middle-aged and older adults found that for every one-percentage-point increase in RDW, all-cause mortality risk rose by about 22%. People in the highest RDW group had roughly double the mortality risk of those in the lowest group, even after adjusting for other health factors.14PubMed Central. Red Cell Distribution Width and the Risk of Death in Middle-aged and Older Adults A separate general-population study confirmed the pattern, finding that high RDW was associated with increased mortality from cardiovascular disease, cancer, and respiratory disease alike.15Scientific Reports. The relationship between red cell distribution width and all-cause and cause-specific mortality in a general population
Before you panic about your own RDW result, some context is important. These are population-level statistical associations, not individual predictions. A slightly elevated RDW does not mean you are in imminent danger. The researchers who study this relationship generally describe RDW as a “non-specific marker”: it picks up that something is off, but it does not tell you what. The broad connection to mortality almost certainly reflects the fact that RDW rises with inflammation, nutritional problems, organ disease, and other systemic stressors that also shorten life. If you have a mildly high RDW and are otherwise healthy, the number is a reason for follow-up investigation, not for alarm.
RDW in Cancer
Elevated RDW has also emerged as a prognostic marker in people already diagnosed with cancer. A meta-analysis pooling data from over 4,200 cancer patients found that high RDW was associated with worse overall survival, with an approximately 47% higher risk of death compared to patients with lower RDW values.16PubMed Central. Prognostic value of RDW in cancers: a systematic review and meta-analysis The association held across multiple cancer types, though the strength varied.
The mechanisms here are not unique to cancer. Tumors produce inflammation. They compete with healthy tissues for nutrients. They can impair bone marrow function directly or through treatment side effects. All of these factors can increase anisocytosis. What makes RDW potentially useful in oncology is that it is cheap and already measured routinely. If it can help stratify which patients are at higher risk for poor outcomes, it adds prognostic value without requiring any additional testing.17PubMed Central. Red cell distribution width and cancer That said, the evidence is still accumulating, and no clinical guidelines currently recommend using RDW alone to guide cancer treatment decisions.
Things That Can Falsely Raise Your RDW
Not every high RDW reading reflects a true underlying problem. Several common situations can push the number up temporarily or confound its interpretation.
- Blood transfusions: Receiving donated red blood cells introduces cells of a different size profile into your bloodstream. Studies in ICU patients show that RDW rises significantly after transfusion and remains elevated for some time afterward.18PubMed. The effects of blood transfusion on red blood cell distribution width in critically ill patients: a pilot study If your blood was drawn shortly after a transfusion, the RDW result may not reflect your own red blood cell production at all.
- Pregnancy: Normal pregnancy causes significant shifts in CBC values. RDW tends to rise progressively from the first trimester through the third, alongside changes in white blood cell counts and other parameters.19PubMed Central. Establishment of reference intervals for complete blood count parameters during normal pregnancy in Beijing An elevated RDW during pregnancy does not necessarily signal a problem; it may just be part of the normal physiological adaptation.
- Smoking: Research has found that smokers tend to have higher RDW values than non-smokers. One study found a statistically significant association between smoking and elevated RDW even after adjusting for age, sex, BMI, and other confounders.20PubMed Central. Associations between smoking and coronary heart disease: mediating role of RDW The chronic oxidative stress and inflammation caused by smoking are the likely culprits.
These confounders matter because they can lead to unnecessary worry or unnecessary follow-up testing. If you have recently had a transfusion, are pregnant, or are a smoker, mentioning that to your doctor when discussing an elevated RDW helps them put the result in proper context.
What to Do If Your RDW Is High
An isolated high RDW is not a diagnosis. It is a prompt for your doctor to look further. The follow-up path depends on the rest of your CBC and your clinical picture. If your hemoglobin is also low, the investigation typically starts with iron studies, B12, and folate levels. If your hemoglobin is normal but your RDW is elevated, your doctor may consider whether chronic inflammation, liver disease, kidney function, or another systemic process could be driving the result. Additional tests like a basic metabolic panel, inflammatory markers such as C-reactive protein, or a peripheral blood smear may be ordered.
One important thing to keep in mind is that a single elevated RDW reading, especially one that is only slightly above the reference range, is not particularly informative on its own. Trends over time matter more. If your RDW was normal six months ago and is now high, that trajectory tells your doctor something different than if it has been sitting at 15% for years. Ask your doctor about your previous results for comparison.
RDW and Atrial Fibrillation
Beyond heart failure, elevated RDW has been studied in the context of atrial fibrillation, the most common type of irregular heartbeat. Several of the same mechanisms are at play: anemia, inflammation, oxidative stress, and kidney impairment can each contribute both to anisocytosis and to the electrical and structural changes in the heart that produce atrial fibrillation.11PubMed Central. Red blood cell distribution width: A marker of anisocytosis potentially associated with atrial fibrillation Whether RDW will ever be clinically useful for predicting or monitoring atrial fibrillation is still an open question. The challenge is that so many different conditions raise RDW that isolating its contribution to any one disease remains difficult. For now, the connection is more a window into shared pathophysiology than a practical diagnostic tool for heart rhythm problems.
Why RDW Gets More Attention Than It Used To
For decades, RDW was treated as a minor number on the CBC, useful mainly for classifying anemias and otherwise ignored. The shift in attention started in the late 2000s when population-level studies began showing that RDW predicted mortality independently of anemia, heart disease, and other established risk factors. That was unexpected. A measurement designed to help sort out types of anemia turned out to be correlated with survival in broadly healthy populations.
The excitement has been tempered by a persistent limitation: RDW is non-specific. A dozen different conditions can raise it, and in any individual patient, the elevated number could reflect iron deficiency, subclinical inflammation, early organ dysfunction, or just being a smoker. That non-specificity means RDW is unlikely to replace any existing diagnostic test. Its future probably lies in risk stratification, helping to identify patients who need closer monitoring or additional workup, particularly in settings like emergency departments and intensive care units where fast, cheap risk assessment has real value. The test costs nothing extra since it is already bundled into every CBC. The information it provides is genuinely useful when interpreted in the right clinical context, and genuinely misleading when viewed in isolation.